original ) (raw )Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case--control …
Florence Mercier
Clinical therapeutics, 2008
View PDFchevron_right
Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA)
sean robbins
Osteoporosis International, 2011
View PDFchevron_right
Compliance with osteoporosis drug therapy and risk of fracture
Gerry Oster
Osteoporosis International, 2007
View PDFchevron_right
Adherence and profile of non-persistence in patients treated for osteoporosis-a large-scale, long-term retrospective study in The Netherlands
Gerard Ypma , Coen Netelenbos
Osteoporosis Int, 2011
View PDFchevron_right
Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study
Gabriel Sanfélix-Gimeno
Scientific Reports
View PDFchevron_right
A New Look at Osteoporosis Outcomes: The Influence of Treatment, Compliance, Persistence, and Adherence
Enkhe Badamgarav
Mayo Clinic Proceedings, 2006
View PDFchevron_right
Determinants of Oral Medication Compliance in Osteoporosis: The Role of Medication Beliefs
John Schousboe MD PhD
View PDFchevron_right
A model of the public health impact of improved treatment persistence in post-menopausal osteoporosis in France
Denis Pouchain
Joint Bone Spine, 2008
View PDFchevron_right
Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations
Milica Nikitovic
Therapeutic Advances in Chronic Disease, 2010
View PDFchevron_right
Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data
Elizabeth Delzell , Huifeng Yun , pradeep sharma
Arthritis Care & Research, 2012
View PDFchevron_right
Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project
Felix Amsler
Swiss Medical Weekly
View PDFchevron_right
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Os...
andrea ildiko Gasparik
Osteoporosis International, 2019
View PDFchevron_right
Analysis of the costs and consequences of adherence to therapy in hip fracture patients. Results of a longitudinal analysis of
Umberto Tarantino
Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 2011
View PDFchevron_right
Compliance with drug therapies for the treatment and prevention of osteoporosis
C. McLaughlin-miley
Maturitas, 2004
View PDFchevron_right
A systematic review assessing the effectiveness of interventions to improve persistence with anti-resorptive therapy in women at high risk of clinical fracture
Muhammad Javaid
2010
View PDFchevron_right
Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications
V. Rabenda
Calcified Tissue International, 2010
View PDFchevron_right
Therapeutic adherence to osteoporosis treatment
S. Tomková
International journal of clinical pharmacology and therapeutics, 2014
View PDFchevron_right
Medication selection and patient compliance in the clinical management of osteoporosis
Charles Inderjeeth
PubMed, 2016
View PDFchevron_right
Incorporating adherence into health economic modelling of osteoporosis
Bengt Jonsson
Osteoporosis International, 2009
View PDFchevron_right
Patient Adherence to Osteoporosis Medications
Jonathan Adachi
Drugs & Aging, 2007
View PDFchevron_right
The Economics of Improving Medication Adherence in Osteoporosis: Validation and Application of a Simulation Model
John Schousboe MD PhD
The Journal of Clinical Endocrinology & Metabolism, 2011
View PDFchevron_right
Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment
Francis Blotman
BMC Women's Health, 2010
View PDFchevron_right
The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study
Edward Czerwinski
Osteoporosis International, 2020
View PDFchevron_right
The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland
Michael Barry
Value in Health, 2012
View PDFchevron_right
Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009
Charles Inderjeeth
Osteoporosis International, 2011
View PDFchevron_right